| Daily sunscreen application and betacarotene supplementation in prevention of basal-cell and squamous-cell carcinomas of the skin: a randomised controlled trial A Green, G Williams, R Nèale, V Hart, D Leslie, P Parsons, GC Marks, ... The Lancet 354 (9180), 723-729, 1999 | 1197 | 1999 |
| Skin cancer in a subtropical Australian population: incidence and lack of association with occupation Nambour Study Group, A Green, D Battistutta, V Hart, D Leslie, D Weedon American journal of epidemiology 144 (11), 1034-1040, 1996 | 357 | 1996 |
| Histone deacetylase inhibitors trigger a G2 checkpoint in normal cells that is defective in tumor cells L Qiu, A Burgess, DP Fairlie, H Leonard, PG Parsons, BG Gabrielli Molecular biology of the cell 11 (6), 2069-2083, 2000 | 344 | 2000 |
| Head and neck cancer: past, present and future D Chin, GM Boyle, S Porceddu, DR Theile, PG Parsons, WB Coman Expert review of anticancer therapy 6 (7), 1111-1118, 2006 | 330 | 2006 |
| Antitumor activity of 3-ingenyl angelate: plasma membrane and mitochondrial disruption and necrotic cell death SM Ogbourne, A Suhrbier, B Jones, SJ Cozzi, GM Boyle, M Morris, ... Cancer Research 64 (8), 2833-2839, 2004 | 318 | 2004 |
| Identification of six new susceptibility loci for invasive epithelial ovarian cancer KB Kuchenbaecker, SJ Ramus, J Tyrer, A Lee, HC Shen, J Beesley, ... Nature genetics 47 (2), 164-171, 2015 | 314 | 2015 |
| What is transforming growth factor-beta (TGF-β)? D Chin, GM Boyle, PG Parsons, WB Coman British journal of plastic surgery 57 (3), 215-221, 2004 | 249 | 2004 |
| Characterization of the melanoma miRNAome by deep sequencing MS Stark, S Tyagi, DJ Nancarrow, GM Boyle, AL Cook, DC Whiteman, ... PloS one 5 (3), e9685, 2010 | 238 | 2010 |
| Melanocortin-1 receptor genotype is a risk factor for basal and squamous cell carcinoma NF Box, W Chen, RA Sturm, DL Duffy, RE Irving, A Russell, LR Griffyths, ... Journal of Investigative Dermatology 116 (2), 224-229, 2001 | 231 | 2001 |
| Ploidy as a prognostic determinant in surgically treated lung cancer PV Zimmerman, MH Bint, GAT Hawson, PG Parsons The Lancet 330 (8558), 530-533, 1987 | 225 | 1987 |
| Novel markers for poor prognosis in head and neck cancer D Chin, GM Boyle, RM Williams, K Ferguson, N Pandeya, J Pedley, ... International journal of cancer 113 (5), 789-797, 2005 | 211 | 2005 |
| Microarray expression profiling in melanoma reveals a BRAF mutation signature S Pavey, P Johansson, L Packer, J Taylor, M Stark, PM Pollock, ... Oncogene 23 (23), 4060-4067, 2004 | 209 | 2004 |
| Neutrophils are a key component of the antitumor efficacy of topical chemotherapy with ingenol-3-angelate JM Challacombe, A Suhrbier, PG Parsons, B Jones, P Hampson, ... The Journal of Immunology 177 (11), 8123-8132, 2006 | 206 | 2006 |
| Multimodal Polymer Nanoparticles with Combined 19F Magnetic Resonance and Optical Detection for Tunable, Targeted, Multimodal Imaging in Vivo BE Rolfe, I Blakey, O Squires, H Peng, NRB Boase, C Alexander, ... Journal of the American Chemical Society 136 (6), 2413-2419, 2014 | 205 | 2014 |
| Up-regulation of p21WAF1/CIP1 by histone deacetylase inhibitors reduces their cytotoxicity AJ Burgess, S Pavey, R Warrener, LJK Hunter, TJ Piva, EA Musgrove, ... Molecular pharmacology 60 (4), 828-837, 2001 | 186 | 2001 |
| CDKN2A/p16 Is Inactivated in Most Melanoma Cell Lines M Castellano, PM Pollock, MK Walters, LE Sparrow, LM Down, ... Cancer research 57 (21), 4868-4875, 1997 | 178 | 1997 |
| p53 expression and risk factors for cutaneous melanoma: a case‐control study DC Whiteman, PG Parsons, AC Green International journal of cancer 77 (6), 843-848, 1998 | 173 | 1998 |
| Anti-tumour activity in vitro and in vivo of selective differentiating agents containing hydroxamate L Qiu, MJ Kelso, C Hansen, ML West, DP Fairlie, PG Parsons British journal of cancer 80 (8), 1252-1258, 1999 | 168 | 1999 |
| Validating Eaton's hypothesis: Cubane as a benzene bioisostere BA Chalmers, H Xing, S Houston, C Clark, S Ghassabian, A Kuo, B Cao, ... Angewandte Chemie International Edition 55 (11), 3580-3585, 2016 | 161 | 2016 |
| Expression of MUC1 and MUC2 mucins in epithelial ovarian tumours Y Dong, MD Walsh, MC Cummings, RG Wright, SK Khoo, PG Parsons, ... The Journal of Pathology: A Journal of the Pathological Society of Great …, 1997 | 155 | 1997 |
